Kindred Biosciences (KIN) Tops Q4 EPS by 7c

Kindred Biosciences (NASDAQ: KIN) reported Q4 EPS of ($0.29), $0.07 better than the analyst estimate of ($0.36).

For earnings history and earnings-related data on Kindred Biosciences (KIN) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• Huazhu Group Limited (HTHT) Tops Q2 EPS by 37c
• DA Davidson Reiterates Buy Rating on Boost Run (BRUN)